( | ) | ( | ) |
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
No. JPCS-22/015
16 August 2022 | |
Re: | Notification of the Resolutions of the Extraordinary General Meeting of Shareholders No. 1/2022 |
Attn: | Director and Manager, the Stock Exchange of Thailand |
Since the Extraordinary General Meeting of Shareholders No. 1/2022 of JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited ("Company") was held on Tuesday, 16 August 2022 at
1.30 p.m. through electronics media, the Company would like to inform the resolutions of the Extraordinary General Meeting of Shareholders No. 1/2022 as follows:
1. Resolved to approve the change of objectives of utilisation of the proceeds received from the Initial
Public Offering ("IPO"). This agenda was approved by a vote of not less than three-fourths of the total number of votes of the shareholders attending the meeting and entitled to vote, without objection votes by 10% onwards of the total number of votes of the shareholders attending the meeting and entitled to vote, with the following voting details:
Represented as a percentage of the total | ||
number of votes of shareholders attending | ||
Number of Votes | the meeting and entitled to vote | |
Approved | 310,343,000 | 93.9457 |
Disapproved | 20,000,000 | 6.0543 |
Abstained | 1 | included as base for voting calculation |
Invalid Ballot(s) | 0 | |
Total Votes of the Meeting | 330,343,001 | 100.0000 |
2. Resolved to approve the issuance of the warrants to purchase the newly issued ordinary shares of the Company No. 1 (JP-W1) in the amount of not exceeding 227,500,000 units for allotting to the existing shareholders in proportion of their respective shareholding (Right Offering), where allotment ratio of 2 existing ordinary shares per 1unit of Warrant to purchase the Company's ordinary shares
No. 1. This agenda was approved by the majority vote of shareholders attending the meeting and entitled to vote, with the following voting results:
( | ) | ( | ) | ||
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED | |||||
Represented as a percentage of the total | |||||
number of votes of shareholders attending | |||||
Number of Votes | the meeting and entitled to vote | ||||
Approved | 310,343,000 | 93.9457 | |||
Disapproved | 20,000,001 | 6.0543 | |||
Abstained | 0 | included as base for voting calculation | |||
Invalid Ballot(s) | 0 | ||||
Total Votes of the Meeting | 330,343,001 | 100.0000 | |||
3. Resolved to approve the increase of the Company's registered capital amounting to Baht 113,750,000, which to be the new registered capital of Baht 341,250,000, by issuing newly ordinary shares of 227,500,000 shares with a par value of Baht 0.50 per share and the amendment to the Company's Memorandum of Associations, Clause 4. to be in line with the Company's capital increase.
This agenda was approved by a vote of not less than three-fourths of the total number of votes of the shareholders attending the meeting and entitled to vote, with the following voting results:
Represented as a percentage of the total | ||
number of votes of shareholders attending | ||
Number of Votes | the meeting and entitled to vote | |
Approved | 310,343,000 | 93.9457 |
Disapproved | 20,000,000 | 6.0543 |
Abstained | 1 | included as base for voting calculation |
Invalid Ballot(s) | 0 | |
Total Votes of the Meeting | 330,343,001 | 100.0000 |
4. Resolved to approve the allotment of the capital increase ordinary shares for supporting the exercise of rights of the Warrant to purchase the Company's ordinary shares No. 1 (JP-W1) in the amount of not exceeding 227,500,000 shares for allotting to the existing shareholders in proportion of their respective shareholding (Right Offering), where allotment ratio of 2 existing ordinary shares per 1unit of Warrant to purchase the Company's ordinary shares No. 1. This agenda was approved by the majority vote of shareholders attending the meeting and entitled to vote, with the following voting results:
( | ) | ( | ) | ||
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED | |||||
Represented as a percentage of the total | |||||
number of votes of shareholders attending | |||||
Number of Votes | the meeting and entitled to vote | ||||
Approved | 310,343,000 | 93.9457 | |||
Disapproved | 20,000,001 | 6.0543 | |||
Abstained | 0 | included as base for voting calculation | |||
Invalid Ballot(s) | 0 | ||||
Total Votes of the Meeting | 330,343,001 | 100.0000 | |||
Please be informed accordingly.
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
Investor Relations | Ms. Jirada Daengprasert |
Tel. 064 479 1691 | Company Secretary |
Emailir@jsppharma.com | On behalf of the Board of Directors |